We are live on
!
Find out more
SCM
Scopia Capital Management Portfolio holdings
AUM
$112M
1-Year Est. Return
48.41%
This Fund
S&P 500
This Quarter
Est. Return
+5.67%
1 Year Est. Return
+48.41%
3 Year Est. Return
+58.7%
5 Year Est. Return
+80.15%
10 Year Est. Return
+533.22%
AUM
$5.28B
AUM Growth
-$391M
(-6.9%)
Cap. Flow
+$206M
Cap. Flow
% of AUM
3.89%
Top 10 Holdings %
Top 10 Hldgs %
63.93%
Holding
51
New
10
Increased
14
Reduced
8
Closed
13
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$147M |
| 2 |
TMH
Team Health Holdings Inc
TMH
|
+$138M |
| 3 |
Signet Jewelers
SIG
|
+$111M |
| 4 |
iShares MSCI Japan ETF
EWJ
|
+$107M |
| 5 |
FCE.A
Forest City Realty Trust, Inc.
FCE.A
|
+$103M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Perrigo
PRGO
|
+$279M |
| 2 |
SPR
Spirit AeroSystems
SPR
|
+$248M |
| 3 |
TMX
Terminix Global Holdings, Inc.
TMX
|
+$116M |
| 4 |
DST
DST Systems Inc.
DST
|
+$112M |
| 5 |
United Therapeutics
UTHR
|
+$108M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 30.23% |
| 2 | Industrials | 17.68% |
| 3 | Communication Services | 13.2% |
| 4 | Technology | 9.65% |
| 5 | Real Estate | 9.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FCE.A
1
DELISTED
Forest City Realty Trust, Inc.
FCE.A
| $480M | 9.1% |
23,054,733
+5,091,486
| +28% | +$103M |
|
|
SPR
2
DELISTED
Spirit AeroSystems
SPR
| $473M | 8.97% |
8,112,309
-4,564,316
| -36% | -$248M |
|
|
3
United Therapeutics
UTHR
$21.7B
| $466M | 8.83% |
3,248,869
-843,832
| -21% | -$108M |
|
4
Baidu
BIDU
$30.9B
| $365M | 6.91% |
2,217,280
+269,795
| +14% | +$45.9M |
|
5
Netflix
NFLX
$324B
| $327M | 6.19% |
26,384,190
+7,070,210
| +37% | +$83.8M |
|
6
Johnson Controls International
JCI
$83.8B
| $323M | 6.11% |
7,832,383
+1,840,122
| +31% | +$80.6M |
|
7
Itron
ITRI
$4B
| $286M | 5.43% |
4,558,387
| – | – |
|
|
GWPH
8
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $233M | 4.41% |
2,084,567
+199,400
| +11% | +$24M |
|
9
JD.com
JD
$36.7B
| $233M | 4.41% |
9,155,191
+462,060
| +5% | +$12M |
|
10
Zebra Technologies
ZBRA
$16.3B
| $189M | 3.57% |
2,200,328
+495,837
| +29% | +$36.7M |
|
11
Williams Companies
WMB
$87.2B
| $159M | 3.02% |
5,118,285
+218,807
| +4% | +$6.59M |
|
|
TMH
12
DELISTED
Team Health Holdings Inc
TMH
| $145M | 2.75% |
+3,338,649
| New | +$138M |
|
|
HZNP
13
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $131M | 2.48% |
+8,081,650
| New | +$147M |
|
14
CONMED
CNMD
$1.38B
| $123M | 2.32% |
2,774,045
| – | – |
|
|
15
Signet Jewelers
SIG
$3.82B
| $119M | 2.25% |
+1,262,633
| New | +$111M |
|
|
16
iShares MSCI Japan ETF
EWJ
$23.3B
| $105M | 1.99% |
+2,150,745
| New | +$107M |
|
17
PUT
iShares Russell 2000 ETF
IWM
$76.7B
| $101M | 1.92% |
750,600
-2,196,000
| -75% | -$281M |
|
18
Southwest Gas
SWX
$6.28B
| $97.5M | 1.85% |
+1,272,668
| New | +$91.9M |
|
|
NDRM
19
DELISTED
NeuroDerm Ltd. Ordinary Shares
NDRM
| $97.3M | 1.84% |
4,383,358
+1,000,000
| +30% | +$18.7M |
|
20
Travere Therapeutics
TVTX
$5.9B
| $96.3M | 1.83% |
5,089,634
+836,746
| +20% | +$17.1M |
|
|
ACOR
21
DELISTED
Acorda Therapeutics
ACOR
| $85.2M | 1.61% |
37,767
+2,734
| +8% | +$6.5M |
|
22
CNX Resources
CNX
$5.21B
| $80.5M | 1.53% |
5,299,619
+3,609,538
| +214% | +$57M |
|
23
Antero Resources
AR
$11.8B
| $75M | 1.42% |
3,170,738
-35,471
| -1% | -$910K |
|
|
INSY
24
DELISTED
Insys Therapeutics, Inc.
INSY
| $65.6M | 1.24% |
7,131,221
-1,997,792
| -22% | -$22.6M |
|
25
Ligand Pharmaceuticals
LGND
$5.47B
| $52.9M | 1% |
+834,278
| New | +$52.6M |
|
Similar funds
SWM
TFS
WAM
CS
BU
TBFA
VDC
RQS
Scopia Capital Management's Q4 2016 Portfolio in Review
As of Q4 2016, Scopia Capital Management held 51 positions worth $5.28B, down 6.9% from $5.67B the previous quarter. Its ten largest holdings account for 64% of the portfolio.
Scopia Capital Management deployed $206M of net new capital in Q4 2016, opening 10 new positions and adding to 14 existing holdings. Its largest new stake was Horizon Therapeutics Public Limited Company Ordinary Shares: 8,081,650 shares worth $131M.
By sector, the portfolio is most concentrated in Healthcare at 30% of assets, up from 28% a quarter earlier, followed by Industrials and Communication Services.
On the sell side, the largest reduction was Spirit AeroSystems, an estimated $248M trimmed.
- Scopia Capital Management's largest Q4 2016 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 8,081,650 shares worth $131M.
- Scopia Capital Management added most to Forest City Realty Trust, Inc. in Q4 2016, an estimated $103M increase.
- Scopia Capital Management's biggest Q4 2016 reduction was Spirit AeroSystems, cutting an estimated $248M.
- Scopia Capital Management fully exited Perrigo in Q4 2016, selling an estimated $279M.
- Scopia Capital Management's ten largest holdings make up 64% of its $5.28B portfolio in Q4 2016.
- Scopia Capital Management opened 10 new positions and closed 13 in Q4 2016.
- Scopia Capital Management's portfolio value fell 6.9% quarter-over-quarter to $5.28B.
Based on Scopia Capital Management's 13F filing for Q4 2016, filed 15 Feb 2017.